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The changing pattern in the etiology of acute renal failure in Turkey. C.
Utal, C. Yalctndag, E. Baler, R. DOIfinsel, FD. Keleltimur, and M. Yflcesoy,
Erciyes University Medical Faculty, Internal Medicine, Department of Ne-
phrology, Kayseri, Turkey. One hundred forty patients were treated for
acute renal failure (ARF) in the Internal Medicine Department, Intensive
Care Unit of Erciyes University Medical Faculty Hospital between 1983
and 1993. Patients were evaluated for the etiological features of ARF.
Following Compulsory State Law and the new liberal Curettage Law
passed in 1981 and 1983, respectively, the etiological features of ARF were
reviewed in the Turkish literature to detect possible changes in the
etiology of ARF. In studies performed in Turkey before 1982, 31-72% of
ARF were related to obstetric complications and 25% of the total cases
followed criminal septic abortions (CSA). In our 140 cases with ARF the
distribution of the etiological features was as follows: various medical
diseases in 75 (53.6%), surgical operations in 34 (24.2%), and obstetrical
complications in 31(22.4%) patients. Among all cases there were only six
cases of CSA (4.3%). There has also been a decrease in the proportion of
obstetrical cases as well as CSA in other reports which have appeared after
1982 in Turkey. We conclude that this improvement is partly related to the
Compulsory State Law and the new liberal Curettage Law.
Distribution of HLA antigens of patients with terminal kidney failure in
the Turkish population. G. Sönmez, M. Sever, U Akar, F. Savran, A. Sinaz,
N. Harman, and M. cathi, I. U Istanbul Medical Faculty, Department of
Medical Biology, Istanbul, Turkey. We have been determining the tissue
type of patients with terminal kidney disease since 1986. We wished to
determine whether there are any differences in terms of distribution of
HLA antigen between those with terminal kidney disease and the normal
population. Using microlymphocytotoxie techniques, we evaluated the
incidence of class I and class II antigens in 2,087 patients and 3,731
controls. Results were as follows: 43% of the patients expressed class I-A2
antigen, whereas the frequency of this antigen in the control was 45%;
24% of patients had A3 antigen, as compared with 22% in the control
group; B5 antigen was found in 31% of patients and 30% of controls. B35
antigen was found in 33% of both controls and patients. Investigation of
class II group antigens in patients and control group yielded the following:
DR5 was present in 39% of patients and 31% of controls; DR4 was in 39%
of patients and 31% of controls; DR7 was in 35% of patients and 28% of
the controls; DR2 in 18% of patients and 22% of controls. B44 (12), B51,
Bw52 antigens in class I and DR4, DR5, DR7 antigens in class II were
significantly increased in patients, whereas DR2 antigen was significantly
increased in the control group as compared with patients.
Adult polycystic kidney disease and mesangial proliferative glomerulo-
nephritis. S. Payday, N. Seyrelc E. Akoglu, I. Tuncer, M. Ouz, and Y.
Sagliker, cukurova University Medical Faculty, Departments of Nephrology,
Pathology and Radiology, Adana, Turkey. In 1986 a 56 year old women was
admitted to the hospital with a history of heinaturia and flank pain; a renal
biopsy showed mesangial proliferative glomerulonephritis (MPGN). No
pathology was observed on intravenous pyelography (IVP), urine culture
and abdominal ultrasonography. In December 1987, a repeat IVP was
normal. The patient was normotensive and renal function was normal in
1989. Because of repeated hematuria, abdominal ultrasound was per-
formed and no pathology was observed. In December 1989, repeat
abdominal ultrasonography revealed that the left kidney was normal and
the right kidney had multiple cysts. A contrast CT scan showed multiple
cysts in the left kidney, right kidney and pancreas. Family history included
chronic renal failure in the sister and renal calculi in the two nephews.
With these results we changed our diagnosis to one of adult polycystic
disease and MPGN. MPGN and adult polycystic kidney disease are not
often seen together and are rarely reported in the literature. The
observation of cysts on CT scan in this patient with hematuria and flank
pain after 5 years of follow-up was interesting. We conclude that CT scan
is much more sensitive than IVP and abdominal ultrasonography in the
diagnosis of polycystic kidney disease.
Simple renal cystic disease: Prevalence, clinical and morphological
aspects. G. Suleymanlar, H. Ytlmaz, C. Gurses, A. Apaydin, A. Kabaaliolu,
G. Yakupoglu, and E. Lulec( Akdeniz University Medical School, Antalya,
Turkey. Simple renal cystic disease (SRCD) is a common and benign
disorder, the incidence of which increases with age. To demonstrate the
prevalence, general and morphological characteristics of SRCD in our
population, 446 patients (with no renal symptoms or signs, referred to the
Department of Radiology for abdominal ultrasonography) were examined
between January 1993 and May 1993. Forty-six patients out of 446 had
simple renal cysts (10.3%). The remainder constituted the control group.
The average age of patients with SRCD (26 males, 20 females) was 59
13 years (29—94) which was significantly higher than that of the control
group (39 17; 1—83 years; P < 0.0001). Routine physical and laboratory
examinations performed in patients with SRCD revealed hypertension in
13 cases (6.5%). Cysts were single in 33 cases (71.7%) and multiple in 13
(28.3%). SRCD was located in the right kidney in 16 patients and in the
left kidney in 22, and was bilateral in 8. Thirteen cysts were located in the
upper 1/3 of kidney, 11 in the middle 1/3 and 12 in the lower 1/3, while 10
cysts were demonstrated in more than one region. Considering the longest
dimension, the average diameter of cysts was 27 20 mm (9—92 mm).
This study suggests that in our population, SRCD is quite common in the
elderly and generally asymptomatic, with cysts being mostly single and 2—3
cm in diameter.
Prevalence of antibodies to hepatitis C virus among hemodialysis
patients. N. Ank, I. Illek S. Genç, K Cengiz, and N. GOrses, Ondokuz
Mayis University, Faculty of Medicine, Samsun, Turkey. In order to deter-
mine the prevalence of antibody to hepatitis C virus (anti-HCV) and its
correlation with liver dysfunction in our hemodialysis unit, serum samples
of 33 patients receiving chronic hemodialysis were tested for anti-HCV
antibody using second-generation enzyme immunoassay kits (Abbott
Laboratories). Anti-HCV was confirmed to be positive in 22 (66%) of 33
patients, and 13 (59%) of the anti-HCV positive patients were noted to
have elevated serum alanine aminotransferase (ALT) values. The corre-
sponding value for anti-HCV negative patients was 36%. Based on these
findings, it becomes clear that hepatitis C infection is a significant problem
in dialysis units and it plays a pathogenic role in liver disease in
hemodialyzed patients. Every effort must he made for the successful
control of this infection, including separation of infected patients from
other patients and reduction of the need for transfusion.
Prevalence of antibodies to cytomegalovirus and hepatitis B virus in
patients under long-term hemodialysis. A. Oguz, O. 5enturk, A. Telaferli,
N. Ozgune, A. C. UçiIk, and R. Erkoç, SSK Goztepe Hospital, Istanbul,
Turkey. The present study was undertaken to determine the prevalence of
cytomegalovirus seropositivity among hemodialysis patients. The viral
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markers of HBV and the relationship between HBV and CMV prevalence
in these patients were also investigated. The study included 66 patients
with chronic renal failure who were being treated at the SSK Goztepe
Hospital Hemodialysis Unit. An enzyme-linked immunoadsorbent assay
(ELISA) method was used to detect IgG and 1gM antibodies against CMV
and the viral markers of HBV, including HB5Ag, HBeAg, anti-HBs,
anti-HBe, anti-HBcIgG, and anti-HBcIgM. Serum samples of 36 age and
sex-matched healthy blood donors were analyzed by the same method.
CMV IgG antibodies were positive in all of the 66 patients (100%) and 30
of the controls (83%; P < 0.01). Anti-CMV 1gM was positive in 5 patients
on hemodialysis (8%). No anti-CMV 1gM seropositivity was present in the
controls (P > 0.05). Seropositivity for HBV was 75% (N = 50) for
hemodialysis patients and 44% (N = 16) for the control group. HBV
seropositivity was 80% (N = 4) among anti-CMV 1gM positive patients.
These results show that in patients with chronic renal failure undergoing
long-term hemodialysis, CMV seropositivity is very high. This high
prevalence is related to multiple blood transfusions. The significance of
the finding of high HBV seropositivity in anti-CMV 1gM positive patients
is unclear, and the evaluation of this finding will only be possible by
working with larger groups.
Investigation of panel reactive lymphocytotoxic antibodies in chronic
hemodialysis patients. A. C. Akdi1, K Dilek, M. GüllOlO, M. Yavuz, R.
Mistik, F. engul, M Yurtkuran, and K Kilçturgay, Immunology and
Nephrology Departments, Medical Faculty of Uludag University, Bursa,
Turkey. Panel reactive lymphocytotoxic antibodies (PRA) were investi-
gated in 56 chronic hemodialysis patients awaiting renal transplantation.
Immunomagnetically purified T cells and HLA DR positive lymphocytes
from 30 donors were used to evaluate HLA class I and Class II reactivity
by two-color fluorescence. In 36% of patients class I reactive and in 68%
of patients class II reactive lymphocytotoxic antibodies were found. A
significant, positive correlation was found with whole blood transfusion as
a risk factor (P < 0.001): 6.3 1.2 (mean + SEM) units of whole blood
were transfused in PRA negative cases, 15.2 3.7 in PRA positive cases,
and 24.3 8.7 units in patients with a PRA over 50%. In cases with a
history of pregnancy class I and class II reactivity were found to be 12.77
8.13 and 23.81 9.14%, respectively, and in patients without a history
of pregnancy 5.46 and 11.9 3.98%, respectively. A two year follow-up
of 33 patients revealed a beneficial effect of use of erythropoietin (EPO)
which may be attributed to a substantial reduction in the number of blood
transfusions. PRA increased significantly in patients who were adminis-
tered blood and who did not receive eiythropoietin, while no significant
change was observed in r-HuEPO administered patients.
N
PRA positivity, %
1991 1993
Transfusion 7.2 U blood (mean) 12 10.05 6.2 18.75 8.2 (P < 0.05)
No transfusion 21 7.65 2.3 6.75 2.2
r-HuEPO 1.5 U blood (mean) 19 10.9 6.3 10.2 6.1
No EPO 4.8 U blood (mean) 14 9.03 4.2 18.1 6.1 (P < 0.05)
Alterations in renal functional reserve in children with renal involve-
ment and normal serum creatinine level. G. G. Yilmaz and A. G. Güven,
Akdeniz University Medical School, Division of Pediatric Nephrology, Antal-
ya, Turkey. Renal functional reserve (RFR) represents the capacity of the
kidney to increase its level of filtration rate under adequate stimuli, such
as loading with protein. Despite establishing normal limits of RFR in
healthy children, and reports of studies in patients with renal disease in the
literature, this test has not yet been introduced to clinical practice. In this
study we measured the RFR in 20 children who had serum creatinine (Se,)
levels less than 0.9 mg/dl (79 mmol/liter) and a variety of renal diseases
documented by history, laboratory and/or renal biopsy. After 12 hours of
fasting, children were asked to empty their bladders and to drink 20 ml/kg
of water in 30 minutes. Thereafter, they were asked to have a meal
containing 3 g/kg protein as cooked red meat, without adding NaCI and
fats. Urine was collected with voluntary voiding for one hour for the
baseline clearance (Cur) before loading and at every hour for a total
duration of four hours after the meal. RFR was expressed as the maximum
percentage increase in Cr over baseline values. Sr levels obtained at the
beginning of the test were compared by regression analysis with RFR
values. There was a good correlation between 5Cr and RFR values in
subjects with 5Cr less than 0.6 mg/dl (53 mmol/liter) (r = —0.77), but not
in subjects with values of 0.7—0.9 (62—79 mmol/liter) (r =
—0.41). We
conclude that reduction in RFR may reflect the kidney status better than
the 5Cr level.
Prevalence of P fimbria (+) Escherichia coli in childhood urinary tract
infections. B. TOysuz, S. calzlkan, F. Akalin, 0. Nasirolu, L. Sever, and N.
Arisoy, Department of Pediatrics, University of Istanbul, Cerrahpala Faculty
of Medicine, Istanbul, Turkey. Escherichia coli (E. coli), the most common
cause of childhood urinary tract infections, has two types of fimbriae. Of
these, P fimbriae adhere to P receptors on human uroepithelial cells, and
are thus not affected by the flow of urine and carried to the upper urinary
tract. It has been shown that the positivity of P fimbriae is higher in those
patients with acute pyelonephritis caused by E. coli as compared to those
with cystitis or asymptomatic bacteriuria. Our aim in this study was to
estimate the prevalence of P fimbria (+) E. coli in infections of the upper
and lower urinary tracts in simple and complicated urinary infections. The
study group consisted of 71 children with urinary infection caused by E.
coli. There were 53 females and 18 males aged between 1 month and 14
years. P fimbria positivity was determined using an Orion Diagnostica PF
test kit. The type of urinary infection (simple versus complicated) was
determined by physical examination, static renal scintigraphy with DMSA,
abdominal US, and voiding cystourethrography. Sixteen of the patients
(22.5%) were P fimbria (+) as compared with 55 (77.5%) who were
negative. Thirty-seven patients had simple urinary tract infections. The
subgroups were acute pyelonephritis in 3, cystitis in 28, and asyptomatic
bacteriuria in 6. Twenty-four patients had complicated urinary infections,
and we were not able to determine the type of infection in 10 patients. Of
complicated infections, 10 patients had primary VUR, 4 scarred kidneys,
2 renal agenesis, 2 horseshoe kidney, 2 neurogenic bladder, 1 nephropa-
thy, 1 Wilm's tumor, and 1 a duplicated system. Of the P fimbria (+)
patients, 10 had simple and 5 had complicated urinary infections, whereas
in the P fimbria (—) group 27 had simple and 19 had complicated urinary
infections. There was no statistically significant difference in the positivity
of P fimbria between simple and complicated urinary infections (P >
0.05). In the simple infections, the positivity was similar between pyelo-
nephritis and cystitis (P > 0.05).
Plasma fibrinogen, antithrombin III, alpha 2-macroglobulin and alpha
2-antiplasmin levels of children with nephrotic syndrome. A. Noyan, A.
Anarat, M. Deyhim, and N. Dikmen, cukurova University, School of
Medicine, Departments of Pediatrics, Nephrology and Biochemistry, cuku-
rova, Turkey. We studied the plasma fibrinogen, antithrombin III (AT III),
alpha 2-macroglobulin (alpha 2-MG), and alpha 2-antiplasmin (alpha
2-AP) levels of 13 children with nephrotic syndrome (NS) in relapse and
remission and compared then with healthy controls. In patients in relapse
the mean plasma levels of fibrinogen and alpha 2-MG were significantly
increased when compared with patients in remission (P < 0.01 and P <
0.001) or the control group (P < 0.01 and P < 0.05). The mean plasma
level of AT III was significantly increased in remission (P < 0.01) and the
mean plasma level of alpha 2-AP was significantly decreased in relapse
(P < 0.01). A positive correlation of the serum albumin concentration with
AT III and alpha 2-AP levels (r = + 0.53, P < 0.01 and r = +0.49, P <
0.05) and a negative correlation with fibrinogen levels (r = —0.40, P <
0.05) were found. A positive correlation of the serum cholesterol concen-
tration with plasma fibrinogen levels (r = +0.50,P < 0.05) and a negative
correlation with AT III and alpha 2-AP (r =
—0.43, P < 0.05 and r =
—0.66, P < 0.05) were found. A positive correlation was found between
proteinuria and plasma fibrinogen levels (r = + 0.63, P < 0.01) and a
negative correlation between proteinuria and AT III levels (r =
—0.63,
P < 0.01) was found. It is postulated that increases in plasma fibrinogen
and alpha 2-MG levels may contribute to the thrombotic diathesis in
childhood nephrotic syndrome.
Assessment of children found to have urinary tract abnormalities on
prerenal ultrasonographic examination. N. Sarimurat, L. Sever, S. calzl-
kan, C. Buyukunal, M. Elicevik, and V. Ocak, Medical School of Celrahpala,
Cerrahpaa, Turkey. Some abnormalities of kidneys and the urinary tract
may be diagnosed by fetal ultrasonographic examination. Frequently
performed ultrasonography during pregnancy results in an increased
number of prenatally diagnosed newborns. Thus, surgical intervention in
many urological diseases has become possible in the very early days of life
or even in the intrauterine period. In this study, 19 patients with a prenatal
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diagnosis of urinary tract abnormalities are described. The age of the
patients at admission ranged from 1 hour to 9 months. In postnatally
performed ultrasonography, 10 of the 12 patients with a prenatal diagnosis
of unilateral hydronephrosis revealed unilateral hydronephrotic changes,
while bilateral hydronephrotic findings were found in 2 patients. In 4
patients diagnosed as having bilateral hydronephrosis at prenatal exami-
nation, 2 again had findings of bilateral hydronephrosis while 1 was found
to be normal. One of the patients could not be examined because he died
5 hours after birth. A patient with bilateral hydronephrosis and hy-
droureters was diagnosed as having multiple cysts at prenatal examination.
Postnatally performed ultrasonography confirmed the diagnosis in 2
patients, one with bilateral hydronephrosis, bilateral hydroureters and an
enlarged vesica and the second patient with multicystic dysplastic kidney.
Fourteen of the 19 prenatally diagnosed patients had surgical interven-
tions (pyeloplasty in 5 patients with ureteropelvic junction stenosis,
anti-reflux operations in 4 patients, nephrectomy in 2 patients, hemine-
phreetomy, neoureterocystostomy, and ureterocelorraphy in one patient
each) at ages ranging from 8 days to 9 months. Surgical correction was
found to be unnecessaiy in 4 patients, while one patient died 5 hours
following birth.
Acute renal failure in critically ill newborns. N. Kültürsay, H. Tekgul, C.
Kabasakal, and S. Mir, Ege University, Department of Pediatrics, Izmir,
Turkey. Acute renal failure (ARF) is a common clinical problem that is
associated with high mortality rates in neonatal intensive care units. This
prospective study was based on follow-up of 21 pre-term and 9 full-term
critically ill neonates. The incidence, diagnostic feature and early course of
ARF in critically ill newborns were investigated. Criteria for ARF were a
BUN level of >20 mg/dl, a serum creatinine level of >1 mg/dl and/or
oliguria (a urine flow rate of < 1 mI/kg of body weight per hour), persisting
for 24 hours or more. ARF was then verified by estimation of GFR and
creatinine clearance. Once ARF was established, urinary indices [urine/
plasma osmolality ratio, urine Na/K ratio, urine Na level, urine/plasma
creatinine ratio, fractional excretion of sodium (FENa) and renal failure
index (RFI)] were calculated. A presumptive diagnosis of ARF was made
in 14/30 (46.66%) while 16/30 (53.33%) had normal renal function.
Pre-renal ARF was diagnosed in 9/14 (64.28%) patients. Five of the 14
patients with ARF were classified as intrinsic or post-renal ARF (35.71%).
The urinary indices FENa > 2.5% and RFI > 2.5 were noted in all
patients with intrinsic or post-renal ARF. Three babies with pre-renal
ARF and two babies with intrinsic ARF died within 48 hours following
diagnosis. We conclude that only FENa and RFI can be used to
differentiate patient as suffering from renal or intrinsic post-renal ARF.
These urinary indices are reliable in neonates with a gestational age
greater than 33 weeks.
Vaccination with inactivated uropathogenic bacteria in childhood re-
current urinary tract infection. A. Nayir, S. Emre, A. inn, H. A/pay, and
F. Tanman, Division of Pediatric Nephrology, Medical School of Istanbul
University, capa, Istanbul, Turkey. I-lost defense mechanisms are very
important in the etiology of recurrent urinary tract infections. It is claimed
that low urinary sIgA concentrations are causally related to UT!. We
investigated whether secretory IgA and frequency of UT! could be
positively influenced by intramuscular (i.m.) vaccination with inactivated
uropathogenic bacteria (Sulcourovac). Ten girls with a mean age of 10
(5—12) years with 3 or more UTI/6 months were vaccinated with Sulcouro-
vac by i.m. injections three times at weekly intervals. A booster injection
was given after 6 months. Specific 1gM and IgG serum antibodies against
the bacterial antigens were determined by ELISA and the IgA secretory
component (SC) concentration in the urine by radial immunodiftusion
assay. Ten healthy girls with a mean age of 9 (6—13) years without UTI
served as controls. After 3 weeks, serum concentrations of specific 1gM
and IgO antibodies were significantly increased and remained elevated up
to 6 months. At baseline, the urinary IgA SC was below the detectable
limit (0.5 mg/liter) in 8 of 10 patients, while after three months it was
detectable in 8 patients (1.08 0.23 mg/liter). Controls showed a mean
urinary IgA SC concentration of 1 0.19 mg/liter. The frequency of the
UTI was 3.6/patient/6 months before vaccination and dropped to 1.6/
patient/6 months within the first 6 months after vaccination and to
1.2/patient/6 months within the 6 months period after booster vaccination.
It is concluded that i.m. vaccination with Sulcourovac increases IgA SC
production of urothel and reduces frequency of recurrent UTI.
Prevalence of helicobacter pylon antibodies: Relation with dyspeptic
symptoms in uremic patients. C. Uta!, 0. Ozbakir, H. Kthç, R. Dü!ünsel, K
Güven, and M. Yucesoy, Erciyes University Medical Faculty, Departments of
Nephrology, Gastroenterology and Microbiology, Kayseri Turkey. Helico-
bacter pylon (HP) infection is highly associated with histologic gastnitis
and peptic ulcer disease in patients with gastrointestinal symptoms.
Uremic patients are especially prone to develop dyspeptic symptoms and
gastroduodenitis. High urea content of the mucus in the stomach may
predispose to HP infection. We studied IgG and IgA antibodies against
HP and results were correlated with age, duration of dialysis, dyspeptic
symptoms, mean blood urea nitrogen (BUN) levels in 72 (52 receiving
hemodialysis therapy) uremic (GFR < 10 mI/mm) patients and 36 healthy,
non-ulcer dyspepsia controls. IgA and IgG anti-HP antibodies were
present in 34 (47.2%) and 28 (38.9%) of patients, respectively, with 25
patients having antibodies of both type. Dyspeptic symptoms were signif-
icantly more common in IgA and both IgA and IgG positive patients (P <
0.05). There was no correlation between age, duration of dialysis, or mean
BUN levels with presence of HP antibodies or between the results of
dialyzed and non-dialyzed patients groups. In conclusion, the prevalence
of antibodies against HP in uremic patients was higher than healthy
controls, but not higher than in non-ulcer dyspepsia patients. High blood
urea levels and dialysis therapy do not seem to affect the likelihood of
infection. The presence of IgG and IgA anti HP antibodies together in
uremic patients may be considered to indicate HP infection.
Kaposi's sarcoma in renal transplant recipients. S. T. Ecder, M$. Sever,
E. Ar/c, A. Turkmen, A. Ydthz, I. Kthcarslan, A.E. Aydzn, and U. Eldegez,
Medical School of Istanbul, Istanbul, Turkey. In this study, we report 9 cases
of Kaposi's sarcoma developing in renal transplant recipients being
followed-up in the transplantation outpatient clinic of the Medical School
of Istanbul. Between October 1983 and July 1993, 9 of 293 (3%), (206
male, 87 female) renal transplant recipients developed Kaposi's sarcoma.
Eight of the patients were male and one female, with a mean age of 41.9
16.1 (range 20 to 68) years. Two patients had polycystic kidney disease,
one diabetic nephropathy, one chronic pyelonephritis, and one reflux
nephropathy. No etiology was identified in 4 cases. All of the patients
received triple immunosuppressive therapy consisting of cyclosporine A,
azathioprine and prednisolone. In the early post-transplant period, pulse
steroid therapy was administered to one patient and antithymocyte
globulin (ATG) to another. The mean duration between the date of
transplantation and the diagnosis of Kaposi's sarcoma was 10.1 12.2
(range 1—33) months. The lesions were limited to the skin in 6 of the
patients. In addition to the skin, the gastrointestinal tract was involved in
2 patients and generalized Kaposi's sarcoma was noted in one patient.
Cyclosporine A was withdrawn in all of the patients while azothiopnine was
withdrawn or tapered, and steroid therapy continued. In addition to the
decrease in immunosuppression, 3 patients received radiotherapy, 3
chemotherapy, and 1 both radiotherapy and chemotherapy. The remain-
ing 2 patients had only surgical excision of the lesions in addition to
reduction in immunosuppression. Lesions regressed in 8 of the patients
following therapy. Acute rejection responding to pulse steroid therapy was
observed in 2 patients after tapering of immunosuppression. The only
patient with generalized Kaposi's sarcoma died within 1.5 months in spite
of cessation of immunosuppression and chemotherapy with interferon.
One of the patients lost her graft because of chronic rejection, but all of
the other patients are doing well with stable serum creatinine levels, and
the lesions remain in regression. Kaposi's sarcoma is relatively common
following renal transplantation and tapering of immunosuppression, es-
pecially cyclosporine A, affects the prognosis positively.
Effects of oral calcitriol treatment on PT}I, calcitonin and QTc values
in renal osteodystrophy. V. Selculc, A. San, Z. Tonbul, and MD. Onuic,
Atatflrk University, Medical Faculty, Nephrology Department, Erzumm,
Turkey. Seventeen patients (13 male, 4 female) with renal osteodystrophy
were treated with oral calcitriol (0.75 pg/day) for 3 months. Before and
after treatment, serum total calcium, ionized calcium, phosphate, para-
thyroid hormone (PTH), calcitonin, magnesium and potassium levels were
measured. Results were compared with those of 12 healthy volunteers (5
males, 7 females), using Student's t-test (paired or unpaired). Serum
calcium levels were increased following calcitriol treatment (P < 0.0001).
Post-treatment levels were not different from those of the control group
(P> 0.05). While ionized calcium levels were not changed by treatment (P
> 0.05), they were higher before and after treatment than in the control
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group (P < 0.001). Following treatment serum PTH levels decreased (P <
0.001), but calcitonin levels increased (P < 0.01). Before and after
treatment, levels of serum alkaline phosphatase did not differ from those
of the control group (P > 0.05). Serum levels of other ions (magnesium
and potassium) affecting Qtc values did not change after treatment and
they were not different from those of the control group (P > 0.05).
Pre-treatment Qtc values were 0.41 0.03 second, and decreased to 0.35
0.02 second after treatment (P < 0.0001). This post-treatment value was
not different from that of the control group (0.36 0.03 second) (P >
0.05). In patients with renal osteodystrophy, while PTH and Qtc values
decreased following calcitriol treatment, serum total calcium and calcito-
nm levels increased.
Enalapril treatment in post-transplant erythrocytosis (PE). E. 0/c F.
Akçicek, A. coker, E. Karaca, K Balak, E. Akahn, A. Baçz, and 0.
Yararbal, Ege University, Transplantation Center, Izmir, Turkiye. Defined as
an increased hematocrit (Hct) of more than 5 1—52% and a hemoglobin
(Hb) of over 17 gIdl measured twice at an interval of one month,
erythrocytosis is a common complication following renal transplantation.
In addition to headache, fatigue, breathlessness and plethora, patients
may also face more serious complications, such as thromboembolism.
Usually treatment consists of frequent phlebotomy to decrease the Hct
below 52%. After it was shown that angiotensin converting enzyme
inhibitors (ACEI) might cause anemia in renal transplant recipients,
Gaston et al successfully used ACEI in the treatment of PE. Results of a
trial performed in our transplantation center using Enalapril 10 mg/day in
20 PE patients are shown below:
Pretreatment 1st month 2nd month 3rd month
Hct 55.3 29 51.0 3.7 45.9 4.6 40.8 5.2
Hct levels that dropped to 34% and 28% in two patients rose to 46% and
42% respectively in the third month after cessation of treatment. During
the treatment period neither leukopenia nor changes in serum creatinine
levels occurred in any patients. Our results prove that ACEI, an alterna-
tive to phlebotomy, is effective and safe in the treatment of PE. The exact
mode of ACEI on erythrocytosis remains unclear.
Hypothalamic-pituitary-thyroid axis in uremic patients. C. UtaI, F.
Keleltimur, I. Kahraman, R. DuIfinsel, and M Yucesoy, Erciyes University
Medical Faculty, Departments of Internal Medicine and Paediatrics, Kayseri,
Turkey. This study was performed in 20 patients with end-stage chronic
renal failure (CRF) and 10 healthy volunteers. Ten of the patients with
end-stage CRF were on regular hemodialysis treatment (RHD). Serum
TT3, 1T4, FT3, FT4, and TSH levels were measured and the TRH
stimulation test was performed in patients and control subjects. Serum
TSH levels were measured at 14.00, 15.00, 16.00, 17.00, 22.00, 23.00, 24.00,
01.00, and 02.00 to determine the rhythm of TSH; the results were then
compared between groups. TT3, FT3 and FT4 values were found to be
lower in patients with CRF compared with controls (P < 0.05). Mean TT4
and TSH values were in the normal range. The circadian rhythm of TSH
was found to be abnormal in 8 (80%) patients on RHD and in 4 (40%)
patients who were not on RHD. Normal, delayed, or no TSH responses to
TRH stimulation were obtained in patients with CRF. In conclusion, CRF
distorts the circadian TSH rhythm and substantially changes the thyroid
hormone profile by affecting the hypothalamic-pituitary-thyroid axis.
Distortion of circadian rhythm of TSH and TSH response to TRH implies
a defect at the level of hypothalamus and hypophysis.
The effect of diltiazem on cyclosporine dosage and serum concentra-
tions in renal transplant patients. Ozener, R. Lawrence, and E. Akoglu,
Marmara University Medical Faculty, Istanbul, Turkey. The effect of dilti-
azem therapy on serum cyclosporine A (CsA) levels was investigated in
patients following renal transplantation. The study group consisted of 11
patients (7 males, 4 females) with a mean age of 35 13 years. Two
patients had received cadaveric organs, and the remainder received live
related grafts. Patients were transplanted 8 4 months prior to the start
of the study. Baseline serum CsA levels and dosages were recorded prior
to the administration of diltiazem, 120 mg od. Serum CsA levels were
measured each month and the CsA dose titrated to this level. At baseline
serum CsA levels were 112 46 ng/ml and the dose 205 54 mg/day. One
month following the start of diltiazem therapy serum levels had risen to
186 91 ng/ml (P = 0.014) at the same dose of CsA. Three months later
the mean serum CsA level remained elevated over baseline at 160 46
ng/ml (P = 0.015) at a lower dose of CsA (145 41 mg/day; P = 0.0048).
In four patients diltiazem dosage was further increased to 240 mg/day.
One month later mean serum CsA levels had risen from 178 33 ng/ml
to 224 41 ng/mI. Three patients have received 240mg diltiazem daily for
four months. Mean serum CsA levels are 135 29 ng/ml at a daily CsA
dose of 73 23 mg.
Acute renal failure due to rifampicin treatment. C. UtaI, C. Yalçinda
F. Keleltimur, R. Demir, M. Yucesoy, and M. Ozesmi, Departments of
Nephrology and Pulmonary Diseases, Erciyes University Medical School
Hospital, Kayseri, Turkey. In patients treated with rifampicin, acute renal
failure may occur following influenza-like symptoms. The typical symp-
toms in these patients are chills, fever, lumbar pain, oligoanuria, and
hematuria. Serious side effects of rifampicin occur particulary in patients
on intermittent tuberculous therapy with irregular use of rifampicin. We
report five patients who developed acute renal failure following rifampicin
intake. Of 4,800 patients who were given intermittent tuberculous therapy,
we have seen acute renal failure in only 5 patients (0.1%) since 1978, and
all patients showed recovery of renal functions without any complication
after discontinuation of the drug and treatment of acute renal failure. As
rifampicin is still one of the most effective drugs in tuberculous infections,
we conclude that intermittent therapy should not be given up considering
the cost benefit, rarity and reversible nature of rifampicin-induced acute
renal failure.
The frequency of IGA nephropathy in primary glomerular disease and
the diagnostic value of skin punch biopsy and serum immunoglobulin
levels. A. Yildiz, . Tuna, M.. Sever, R. Sarica, S. T Ecder, A. Turkmen, G.
Azizierli, E. Ark, and E. Ozdogan, Medical School of Istanbul, Istanbul,
Turkey. In this prospective study, 24 patients in whom renal biopsy was
performed with a probable diagnosis of primary glomerular disease at the
Nephrology Department of Medical School of Istanbul between 12/10/
1991 and 7/14/1992 are described. Eight of 24 (33%) patients were found
to have IgA nephropathy. Four of them were male and 4 female with a
mean age of 22.5 6.5 (range 15—35) years. Skin punch biopsy was carried
out in 7 patients and no significant IgA deposition was detected in dermal
capillaries. Two of the 8 (25%) patients had high serum IgA levels. The
higher incidence of IgA nephropathy in some countries is attributed to
routinely performed screening tests and frequently performed kidney
biopsies in asymptomatic urinary abnormalities. Our relatively high rate of
IgA nephropathy can be explained on the basis of a high index of suspicion
and wide indication for kidney biopsy in patients with asymptomatic
urinary abnormalities. In conclusion, IgA nephropathy is not an infre-
quent disease. In the diagnosis of this disease, we suggest that measure-
ment of serum IgA levels is helpful, although skin punch biopsy was not
found to be useful.
The effect of triple therapy on rapidly progressive glomerulonephritis
(RPGN) in Henoch-Schonlein purpura. A. Oner, K Tinaztepe, and 0.
Erdoan, Dr. Sami U/us Children's Hospital and Haccetepe Faculty of
Medicine, Units of Pediatric Nephrology and Nephropathology, Turkey.
RPGN is a medical emergency with a serious prognosis unless treated
intensively. In this study, twelve cases of HSP presenting as RPGN
in-patients aged 6—14 years (mean 10.3) were investigated from the
clinical and pathological points of view, with emphasis on the effect of
therapy and prognosis. Renal biopsies were aveliable in nine of the cases
and revealed necrotizing and a fibroepithelial type of crescentic glomer-
ulonephritis (with 60—90% crescent formation). The remaining three
patients fulfilled the clinical criteria of RPGN. Analysis of the initial
clinical features revealed edema (8/12 cases), hypertansion (7/12 cases),
gross hematuria (11/12 cases), oliguria (5/12 cases) and decreased glomer-
ular filtration rate (GFR, 40 ml/min/1.73 m2, 8/12 cases). Two patients who
were in the acute stage required peritoneal dialysis for a period of two
weeks. The treatment protocol in all patients consisted of intravenous
pulse methylprednisolone (3 days), oral cyclosphosphamide (2 months),
oral dypiridamole (6 months), and oral prednisolone (3 months). At the
end of triple therapy, GFR returned to normal values in all cases except
one. On follow-up, over a period of 6—36 months, seven patients achieved
complete remission, while four patients showed partial remission, three
with persistence of proteinuria and hematuria, and one with microscopic
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hernaturia. One patient had persistent nephropathy with decreased GFR
and macroscopic hematuria and nephrotic range proteinuria (40 mg/rn2!
hr). His renal biopsy performed 30 months after the onset of the disease
showed chronic diffuse scierosing glomerulonephritis and severe intratu-
bular IgA deposition. Although our patient group was small, this type of
intensive treatment appears to be effective, but further studies need to be
performed.
Antihypertensive effect of benazepril in patients with chronic renal
failure undergoing hemodialysis. M Soydan, Z. Eren, and 0. Onbal4
Anadolu University Faculty of Medicine, Turkey. In order to examine its
antihypertansive effects and its influence on renal function, an angiotensin
converting enzyme inhibitor benazepril was given to 10 chronic renal
patients undergoing hemodialysis in doses ranging from 5 to 20 mg/day.
The group consisted of 6 male and 4 female patients with an average age
of 44.5 18 years. The creatinine clearance of patients was 6.07 4.67
mi/mm. In this study systolic, diastolic and mean diastolic blood pressures,
heart rate, ECG, blood biochemistry, complete blood count and urine
analysis, renin and aldosterone values were examined. The mean systolic
blood pressure was 174 7.19 mm Hg before treatment, and then fell to
164 + 12.6mm Hg (P < 0.05). Mean diastolic blood pressure fell from 99
4.07 mm Hg to 90 2.36 mm Hg (P 0.05), plasma renin levels from 7.41
2.24 pg/mi to 4.66 1.16 pg/mi, aldosterone level from 382 158.64
pg/mi to 252.92 118.4 pg/mI (P < 0.05). We observed coughing in two
patients and orthostatic hypotension in one patient. It is evident that
benazepril has a significant antihypertensive effect in hemodialysis pa-
tients. However, since values of both systolic and diastolic pressure
remained elevated, benazepril should combined with other antihyperten-
sive agents.
Changes in left ventricular function in patients with chronic renal
failure on CAPD: A preliminary report. G. Suleymanlar, S. Yalcinkaya, E.
Semiz, H. Yilmaz, M. Sapan, F. Ersoy, G. Yakupol, and U.N. Defer,
Akdeniz University Medical School, Antalya, Turkey. It is known that left
ventricular hypertrophy and dysfunction increase the cardiovascular mor-
bidity and mortality in patients with end-stage renal disease. To assess the
effect of CAPD on systolic and diastolic ventricular function, we per-
formed echocardiography and pulsed Doppler echocardiography in 14
CAPD patients before and 3 months after starting CAPD therapy. The
mean age of the 14 patients (9 males, 5 females) was 44 + 12 (19—63)
years. Systolic and diastolic blood pressures fell after three months APD
(P < 0.02), while hemoglobin levels were unchanged. PTH-C and PTH-M
levels were significantly decreased (P < 0.02). There was no change in the
dimensions or volumes of the left ventricule or in systolic function (EF)
upon echocardiographic examination. Left ventricular diastolic function
was assessed by LV filling parameters, such as peak early and atrial filling
velocities and their ratios in pulsed Doppler echocardiography. No change
was observed in any of the diastolic LV filling parameters after CAPD
therapy. LV muscle mass and LV volume/mass relations were not different
from the baseline values. Our data suggest that short-term CAPD therapy
did not significantly change systolic and diastolic LV function in spite of
improvement in blood pressure and metabolic status. However, further
efforts should be made to evaluate the long-term benefits of CAPD.
Two patients with Kapusi's sarcoma after renal transplantation. H.Z.
Tonbul, A. San, Y Selçuk, H. Kaa, and M.D. Onuk, Clinics of Nephrology,
Faculty of Medicine, Ataturk University, Turkey. In the last ten years, a total
of 20 patients who underwent renal transplantation either in Turkey or
abroad were followed by our clinic. In 2 of them (10%), Kaposi's sarcoma
(KS) occurred and no other malignancy was seen. In the literature there
are few reports of KS occurring after renal transplantation. The two
patients with KS were male, aged 42 and 52. One of them underwent renal
transplantation from an unrelated live donor in India. The other under-
went cadaveric renal transplantation in Turkey. Both patients were taking
prednisolone 12.5 mg/day, azathioprine 100 mg/day, and cyclosporine A
200 mg/day as the immunosuppressive treatment. In the first patient KS
associated with visceral involvement developed 6 months after transplan-
tation. Immunosuppressive treatment was then stopped. Interferon and
chemotherapy were ineffective. He returned to hemodialysis because of
rejection and died a year following transplantation. The second patient
had KS associated with skin involvement which developed 11 months after
transplantation. Skin lesions became lighter after reduction of the immu-
nosuppressive dosage. Now, 5 months after the diagnosis of KS, visceral
involvement has not developed and he lives with a functioning graft.
Living unrelated kidney transplantation in India: High risk of compli-
cations other than the well-known ethical problem. M.5. Sever, S. T Ecder,
A.E. Aydin, A. Tflrkmen, I. Kilicaslan, S. calangu, M. carin, and U Eldegez,
Medical School of Istanbu4 Istanbul, Turkey. Due to inadequate cadaveric
and living related organ supply, many end-stage renal disease patients go
to third-world countries for living unrelated (paid) kidney transplantation.
Thirty-four patients who have had transplantation in an Asian country
before coming to our center for post-transplant care and follow-up are
reported in this study. In the post-transplant phase at our center, the mean
follow-up period of the patients was 209.7 137.3 days (range 6 to 450
days). Fourteen of them, having an uneventful course, were followed on an
out-patient clinic basis. The remainder of the patients were hospitalized
because of the following surgical and/or medical complications: urinary
fistula in two patients, lymphocele in three patients, urinary tract obstruc-
tion in two patients, decubitus ulcer in one patient, severe wound infection
in one patient, subacute myocardial infarction in one patient, acute
irreversible vascular rejection in two patients, chronic rejection in two
patients, urinary tract infection in two patients, pneumonia in two patients,
congestive heart failure and severe electrolyte disturbance in two patients,
post-transplant diabetes mellitus and ketoacidosis in one patient, cycio-
sporine A nephrotoxicity in two patients, cyclosporine A nephro-, hepato-
and neurotoxieity in one patient. Plasmodium falciparum malaria in three
patients, generalized mucormycosis infection in one patient, and genito-
urinary aspergiliosis in one patient were noted during the first month.
Hepatitis B virus infection was diagnosed in two patients 2 and 4 months
after the operation, and Kaposi's sarcoma was noted in another two
patients 1 and 5 months after the operation. One of the patients died as a
result of disseminated mucormycosis and another one as result of pneu-
monia. Transplant nephrectomy was performed in the case of two other
patients because of irreversible rejection. A possible cause of the above-
cited high incidence of complication was thought to be the inadequate
evaluation of the donors and the patients in the preoperative period.
Furthermore, many of the patients were sent to their countries without the
treatment of postoperative period complications. It is concluded that
living unrelated (paid) kidney transplantation in developing countries
carries high risks of medical and/or surgical complications, in addition to
the apparent ethical problems.
Accuracy of the urine analysis using disposable napkins: An experi-
mental study. U. G. Yilmaz and A. G. Gflven, Akdeniz University Medical
School, Division of Pediatric Nephrology, Antalya, Turkey. Measurements of
urinary constituents give important information in clinical practice and in
renal and metabolic studies. Obtaining urine specimens by urine bags in
infants is difficult and may cause discomfort and excoriation of the skin. In
this study we investigated the accuracy of the measurement of urinary
constituents using urine extracted from disposibie napkins, which is a
simple, non-invasive, rapid and inexpensive technique. Urine was obtained
from children following voluntary voiding and each specimen was analyzed
in three different ways: (a) sample directly analyzed; (b) urine samples
poured onto the napkins; (c) the same amount of urine poured into the
napkin after removing the outer layer. Urine from the damp area from the
napkins was collected using sterile gloves. Damp fibers were pushed into
the barrel of a 50 ml disposible syringe from which the plunger had been
removed; urine was readily obtained by replacement of the plunger and
compression of the fibers. Each group consisted of 15 samples. There was
complete agreement among samples collected by the three techniques in
measurements of specific gravity, pH, glucose, protein, creatinine, potas-
sium, phosphorus, quantitative protein, bacteria counts and culture re-
sults. Sodium was found in higher concentrations and urine volume, white
cells and casts were found in diminished numbers in groups B and C. We
conclude that this procedure gives us the opportunity to obtain reliable
measurements of most urinary constituents and may be used in clinical
practice and in research.
Chronic renal failure due to Behcet's syndrome associated with sys-
temic amyloidosis. C. UtaI, S. Uta, . tlrsoy, 0. Kontal, F. Keleltimur, and
R. Dulunsel, Erciyes University Medical Faculty, Departments of Internal
Medicine (Nephrology), Dermatology and Patology, Kayseri, Turkey. Beh-
syndrome is recognized as a multisystem disease with mucocutane-
ous, ocular, vascular, articular, gastrointestinal, and neurological involve-
ment. The association of Behcet's syndrome with amyloidosis is not
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common. We present a patient who developed end-stage chronic renal
failure due to systemic amyloidosis associated with Behcet's syndrome. A
35 year-old man was admitted to our hospital and peritoneal dialysis was
performed because of hyperkalemia and severe uremic acidosis. The
medical history and clinical findings were compatible with incomplete
Behcet's syndrome. The rectal biopsy showed minimal colitis and was free
of amyloid, while the renal and bone marrow biopsies showed amyloid
deposits. The chronic inflammatory process in Behçet's syndrome may be
the possible etiopathogenetic factor for systemic amyloidosis.
Nephrotic syndrome due to AA type amyloidosis in asymptomatic
Behçet's disease with a ten year period. K Dilek M. Güllüld, A. Ersoy, M.
Yavuz, M. Yurtkurank and Tinaztepe, Uluda University Medical Faculty
Department of Nephrology, Bursa, and Hacetrepe University, Medical Faculty
Department of Pediatrics, Ankara, Turkey. In Behcet's disease, renal
amyloidosis with nephrotic syndrome secondary to this is an uncommon
clinical case. Although our 27 year-old male patient had been asymptom-
atic for 10 years, he applied to our clinic with nephrotic syndrome. AA
type renal amyloidosis was established on renal biopsy. The case is
discussed in the light of data in the literature. It is emphasized that
amyloidosis may develop even in Behcet's disease which has been asymp-
tomatic for a long time and that patients should be followed-up with this
in mind.
The evaluation of renal osteodystrophy by regional bone density in
patients on maintenance hemodialysis. N. Seyrek, S. Payday, A. Uluhan, M.
Altay, M. Oguz, and Y Sagliker, cukurova University Medical Faculty,
Department of Nephrology and Radiology, Adana, Turkey. Regional bone
density (RBD) was measured by quantitative computer tomography(QTC) in 21 patients on maintenance hemodialysis (HD). The male!
female ratio of the patients was 13!6 and the mean age was 36.76 13.13
(range 16—60) years. None of the patients received corticosteroids nor was
diabetic. An increase in RBD was detected in 7 (33%) of the cases.
Fourteen of the patients (66%) had a decrease of RBD. The decrease in
RBD was between 10% and 45%. There was no correlation between the
decrease in RBD and serum calcium (Ca), phosphorus (P), alkaline
phosphatase (ALP), microglobulin (M), total parathormone levels (PTH),
age or duration of HD. Although our study was a small group, obvious
bone loss in young patients was an important finding in our study. We
conclude the levels of serum Ca, P, ALP, total PTH and M may not always
predict the severity of renal osteodystrophy.
Effects of various cytoprotective agents on urine output from the
kidneys exposed to cold ischemia. A. Kuzu, I. Ala C. Koksoy, O.
Yazar, E. Kuterdem, and R.K Turker, University of Ankara, Departments of
Surgery and Pharmacology, Ankara, Turkey. The duration of cold ischemia
is one of the most important factors responsible for delayed graft function.
The aim of this study was to investigate the effects of iloprost (10 M), a
stable prostacyclin, a stable prostacyclin, UK 38485 (10 M), a thromboxane
synthetase inhibitor, BM 13177 (10 M), a thromboxane receptor blocker,
nicardipine (10 M), a calcium channel blocker, on altered renal function
due to cold ischemia for 24 and 72 hours. The experiments were
performed in isolated perfused kidneys from adult rabbits. Kidneys in
separate series of experiments were perfused with Euro-Collins containing
iloprost, UK 38485, BM 13177, nicardipine and incubated with the same
solution in a beaker exposed to cold ischemia for 24 and 72 hours at 24°C.
The same procedure was applied to the control kidney in EC solution
alone. The changes in urinary flow were recorded (ml!10 mm) throughout
the experiments and the responses to various vasoactive substances were
recorded and compared.
Groups
Urinary outpUt, ml!1O mm
24 hours 72 hours
EC (12) 8.1 1.2 1.2 0.2
EC + iloprost 16.2 2.2 3.9 1.1
EC + UK 38485 (13) 16.6 1.5 7.5 1.4
EC + BM 13177 (6) 12.3 1.1 —
EC + nicardipine — 12.3 1.2
Values are expressed as mean + SEM. Numbers in parentheses repre-
sents the number of experiments.
These results show that the addition of cytoprotective agents to standard
preservation solutions significantly improves urinary excretion (P < 0.05).
Hepatitis B and C infections in hemodialysis and CAPD patients:
Comparative results. G. Suleymanlar, H. Yilmaz, M. Sapan, F. Ersoy, I.
Suleymanlar, F. Ilitan, M. Gultekin, L. Undar, N. Bilal, and G. Yakupolu,
Akdeniz University Medical School, Anralya, Turkey. The clinical impor-
tance of hepatitis infections in dialysis patients is constantly increasing
because of high prevalence and serious clinical outcome. In order to assess
the frequency of and risk factors for HBV and HCV, we evaluated the
serial results of HBsAg and anti-HCV (2nd generation) measured by the
ELISA method in HD and CAPD patients. The mean age of 44 HD
patients (15 female, 29 male) was 35 3 (13—72) and was 45 2 (18—79)
in 51 CAPD patients (23 female, 25 male), while 2,942 healthy blood
donors were the control group. In the control group, the prevalences of
HBsA positivity and anti-HCV positivity were 7.99% and 0.75%, respec-
tively. Serologic markers in patients groups were as follows:
CAPD
Serology
HD(N =
N
44)
% N
(N= 48)
% P
HBsAg(+) 13 29.5 2 4.2 0.001
HBsAg(—) 31 70.5 46 95.8
Anti-HCV(+) 17 38.6 9 20.9 0.07
Anti HCV(—) 27 61.4 34 79.1
The prevalence of HBsAg positivity and anti-HCV positivity in HD and
CAPD patient groups was significantly higher than the control group (P <
0.0001). Although the HB5Ag positivity was significantly higher in the HD
group compared with the CAPD group, HCV antibody positivity did not
differ significantly. When it is taken into account that 6 of the 9 anti-HCV
positive patients in the CAPD group were transferred from HD, a
significant difference arises between the two groups. Duration of dialysis
on HD was longer than that on CAPD [23 3 (13—72) months and 11
1 (1—29) months respectively, P < 0.001]. The mean number of blood
transfusions in the HD group was 5 units, while no transfusions were made
in the CAPD group (P < 0.0002). There was no difference between two
groups in terms of HB vaccination and liver disease. In the dialysis patient
population, the prevalence of HBV and HCV infections is higher than in
the general population. The risk of viral infection is significantly higher in
HD patients than in CAPD patients. The number of blood transfusions
and the duration of dialysis should be considered as risk factors for high
infection rate among these patients.
Hepatic markers of chronic adult hemodialysis (HD) patients: A
retrospective study investigating etiologic correlation. E. Ozdemir, E. Ok,
S. Kdrat, M. Cirit, K Balak, H. Töz, E. Akalin, and G. Atabay, Department
of Nephrology, Ege University, Izmir, Turkey. Both HCV and HBV infec-
tions are common and disabling diseases among HD patients. The aim of
this study was to study multiple etiologic correlations in hepatitis. Sixty-
seven patients (33 men, 34 women; mean age 41.2 years, range 17—66
years) who were in the hemodialysis program at our unit were investi-
gated. Results were as follows:
N %
Patients 67
Anti-HCV 31 46.3
HB5Ag 5 7.5
Anti-HBs 46 68.6
Anti-HCV and HBsAg 3 4.5
ALT (increased), U!liter 13 19.4
Anti-HCV(+) Anti-HCV(-) P
ALT (increased), U!liter 10 3 0.05
ALT (normal), U!liter 21 33 0.05
Mean HD Time, months 44.7 4.4 25.3 2.8 0.001
Blood transfusions, Units 32.4 6.0 12.5 2.9 0.01
Abstracts 1681
HBsAg(+) HBsAg(—) P
ALT (increased), U/liter 1 12 NS
ALT (normal), U/liter 4 50 NS
Mean HD time, months 41.6 12.8 33.9 2.9 NS
Duration of HD treatment appears to be the most important determinant
of anti-HCV positivity (P < 0.0001). The relation between blood transfu-
sions and anti-HCV was less significant (P < 0.01). On the other hand,
ALT levels predict anti-HCV positivity to a certain limit. Unexpected
results of HBsAg positive patients regarding HD duration may be
explained by the effect of the small size of HBsAg positive patients to the
statistical analysis. Unexpected non-significant difference among HB5Ag
positive and negative patients in regard to HD duration may be explained
by uneven distribution of the patients in both groups.
Comparison of blood levels of creatinine kinase and lactic dehydroge-
nase and their izoenzymes in dialysis patients. A. celik, T. camsan, M.
Fadiloglu, T Seronkolç, and B. Ozen, Dokuz Eylul University, Faculty of
Medicine, Nephrology Unite, Izmir, Turkey. In this study of hemodialysis
and CAPD patient groups, CK, LDH and their isoenzymes were com-
pared by the electrophoretic method. Twenty-seven hemodialysis and 14
CAPD patients were studied. The control group consisted of 14 healthy
volunteers. Patients with histories of angina pectoris, myocardial infarc-
tion, surgery trauma, etc., were eliminated because of their possible effects
on enzyme levels. The results are summarized in Table 1 for LDH and in
Table 2 for CK.
Table 1.
LDH-Total lU/liter LD1, (%) LD2, (%)
HD
CAPD
P
361.77 5.77 36.11 4.83
291.21 55.7 34.95 4.83
> 0.05 > 0.05
32.85 3.22
35.85 53.22
>0.05
LD3,(%) LD4, (%) LD5, (%)
HD
CAPD
P
20.1 1.77 3.23 1.17
18.0 1.77 3.85 1.7
> 0.05 > 0.05
7.93 2.07
7.14 2.07
> 0.05
Table 2.
CK-Total lU/liter CK-BB, (%) CK-MB, (%) CK-MM, (%)
HD
CAPD
P
90.1 6.0 17.00 3.20 27.41 4.69
115.42 30.44 20.22 3.20 22.51 4.69
> 0.05 > 0.05 > 0.05
55.71 6.36
53.37 6.322
> 0.05
Abbreviations are: CK-BB, brain component; CK-MB, myocardial
component; CK-MM, skeletal muscle component.
CK, LDH and their isoenzymes (CK-BB, CK-MB, CK-MM, LDH1-5)
showed no significant difference between CAPD and HD groups. With the
exception of LDH4, the same results were obtained when each group was
compared with the control group. There was a significant difference
between dialysis groups (CAPD and HD) and the control group for
LDH-4, although CAPD and HD groups showed no difference between
each other in respect to isoenzyme. To our knowledge there is no known
association of this isoenzyme with a specific disease. In conclusion, there
are no significant differences between CK, LDH or their isoenzymes in
HD or CAPD patients.
Peritoneal equilibration test (PET) in CAPD patients. M. Sapan, H.
Bozcuk, M Akbulut, and F.F. Ersoy, Akdeniz University Medical School,
Antalya, Turkey. In order to determine dialysis efficiency and ultrafiltration
dynamics, we performed PET in 13 CAPD patients in our CAPD patient
group. Following administration of two liters of PD II into the peritoneal
cavity, dialysate (D) and plasma (P) creatinine and glucose levels were
measured at 0, 2, and 4 hours. For glucose, D2/D0, D4/D0 and for
creatinine DO/PO, D2/P2, D4/F4 ratios were calculated and results were
evaluated using the standard PET diagram. Two patients were poor, 6
patients low average, 3 patients above average, and 2 patients were high
glucose absorbers. Creatinine DIP values were also calculated to assess
peritoneal permeability to creatinine. We have rearranged our patients'
CAPD prescription in order to get the maximum benefit of their dialysis
based on the information provided by PET.
Diuretic effects of intravenous furosemide (F), albumin (A) and the
combination (F+A) in massive edema due to nephrotic syndrome (NS). F.
Aciçek A. Balci, Ozballi, M. F. Yalniz, C. coker, 0. Zirelç A. Tanyiimaz,
and E.J. Dorhout Mees, Department of Nephrology, Ege University, Izmir,
Turkey. It has been recently established that administration of A is
ineffective in provoking a diuresis in most patient with NS. There is,
however, a clinical impression that A potentiates the natriuretic action of
F. We compared the effects of A (0.5 g/kg), F (60 mg iv. followed by 40
mg/hr over 4 hours) and of the two combined in 8 nephrotic patients with
severe Na retention. Treatments were given in random order, separated by
at least 2 control days. Infusion of A caused a rise in serum albumin from
1.73 0.23 to 2.36 0.24 g/liter, with a mean increase in plasma volume
of 30% (calculated from Htc change). The excretion rates of water (V,
mi/mm), sodium (Na, mcEq/min), and potassium (K, mEq/min) are given
below:
EXC C F C A C F+A
V 0.72 0.25 6.8 3.4 0.81 0.28 1.1 0.62 0.78 0.55 7.3 4.3
Na 17 13 740 374 30 21 50 38 15 5.3 690 456
K 18±5 72±26 24±7.3 24±24 19±7 72±34
Despite large individual variations, the effect of A on Na excretion was
very limited as compared to that of F alone. The addition of A to F did not
increase the effect of F alone. The urinary excretion of F was not enhanced
by infusion of A. The F/Na ratio in the urine varied over a 10-fold range,
suggesting that parts of the nephron other than F sensitive play a major
role in the Na retention. Apart from arguing against the "hypovolemia
concept" our results do not confirm the suggestion that addition of A to F
is useful in the treatment of NS.
Aluminum monitoring and toxicity in hemodialysis patients. F. Kara-
kullukcu, M. Kflçuk, H. Polat, and K Onsun, SSK Istanbul Hospital,
Department of Hemodialysis, Istanbul, Turkey. Aluminum is found naturally
in small amounts in the body and its function is not totally known. In
hemodialysis patients, intestinal absorption of aluminum from A1OH}3
preparates used to prevent the intestinal absorption of phosphate, and
aluminum present in dialysis fluid and parenteral solutions that cannot be
eliminated by urine, are the causes of tissue accumulation of aluminum
and aluminum toxicity. We have estimated basal aluminum levels (BSAD)
in 126 patients in our unit. BSAD values were found to be high in 38% of
the cases and the desferrioxamine (DFO) test was carried out in these
cases. Results were positive in 86% of cases. Cases with high and normal
BSAD values were compared according to the parameters of age, sex, and
primary cause of disease; no difference was found. A linear relationship
was detected between BSAD values and duration of hemodialysis. BSAD
values of patients with more than 3 years of hemodialysis were statistically
different than those of patients with 1—3 years of hemodialysis, and
significantly higher than patients dialyzed less than 1 year. In patients with
a positive DFO test, 27% were clinically aluminum toxic. In those patients
with a positive DFO test, hematocrit, erythroeytes and hemoglobin levels
were found to be low.
The evaluation of 7 renal transplantation cases performed in India. E.
Akbay, T Arisoy, S. Sindel, and M Ba14 Turkey. In this study clinical,
immunological, biochemical, and hematological parameters and infectious
complications of 7 renal transplantation patients following live unrelated
transplantation in India but now attending G.U. Nephrology outpatient
clinic were evaluated. The graft functions and graft and patient survival
ratios were obtained. The HLA compatibility of the patients was investi-
gated and 1—3 mismatch in Class I antigens and 0—3 mismatch antigens
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Class II antigens were found. In 4 cases triple (CsA+Pred+Aza) and 3
cases double (CsA+Aza) immunosuppressive treatment was used. In one
patient CsA was stopped because of increasing transaminase values and
treatment was continued with cyclophosphamide. Two patients were
female and 5 patients were male. Average follow-up time was 11.2 6.3
(1—18) months. In 5 patients graft function was good. Chronic rejection
developed in one patient and the patient entered our hemodialysis
program. One patient died of sepsis. In the group of patients whose graft
function was normal, average systolic blood pressure was 142.1 25.8 mm
Hg (110—175 mm) and the average diastolic blood pressure was 87.1 9.9
mm Hg (70—100 mm). Blood pressure was regulated in three patients by
medical treatment. In this group the average NPN value was 49.6 10.3
mgldl (32—58 mgldl), the average creatinine value was 1.4 0.3 mgldl
(0.9—1.7 mg/dl), the average hamatocrit value 35.6 3.8% (30.9—41.3%),
and the average hemoglobin value 12.9 1.89 gJdl (9.3—14.4 gldl). The
mean 24 hour urinaly excretion was 331 100 mg (235—485 mg) and the
average serum creatinine level was 51.3 22 mg/dl (32—80 mg/dl). In one
case CsA was stopped because of increasing serum transaminase levels
and treatment was continued with cyclophosphamide. In one case de-
crease in liver size, echo heterogenicity, and ascites were found on
ultrasonic evaluation. In both cases anti-HCV was positive. In all cases
HBsAg was negative. One patient died of sepsis due to pulmonary
infection in the early postoperative period. In one case pulmonary
tuberculosis was found and anti-tuberculosis treatment was given. CMV
1gM was negative in all cases. The 11.2 month graft survival rate was
71.4% and the patient survival rate was 85.7%.
